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Clinics 
Age and sex: 56 year s old male patient. 
Previous History:  
- no preleukemia  
- no previous malignant disease (but coincident CLL at 
the same time of AML diagnosis. No prior therapy for 
CLL); 
- no inborn condition of note. 
Organomegaly:  
- no hepatomegaly;  
- no splenomegaly;  
- no enlarged lymph nodes. 
Blood 
WBC: 52.2 x 109/l; Hb: 10.2 g/dl; platelets: 158.0 x 
109/l; blasts: 86% (peripheral blood). 
Bone marrow: Bone Marrow Differential:  
- Cellularity : o.k. 
- Megakaryocytes : present  
- Blasts : 66% 'blast like' immature forms  
- Promyelocytes : 1%  
- Myeloid Activity : 13%  
- Erythroid Activity : 6%  
- Lymphocytes : 13%  
- Other : - 
Cytopathology classification 
Cytology: M0. 
Immunophenotype: A population of immature cells 
positive for CD45(dim), HLA-DR, CD7, CD34 
(majority) and myeloid markers CD33 and CD13, with 
absence of staining for B cell, monocytic, and other T  
 
cell markers, consistent with myeloblast. A minor 
clonal kappa positive (moderate intensity) population 
of CD5 positive B cells which were negative for CD23 
was also detected, suggesting a co-existing CD5 
positive B cell lymphoproliferative disorder. A minor 
population of CD19 positive B cells co-expresses CD5 
and exhibits monotypic surface immunoglobulin kappa 
light chain staining, consistent with involvement by the 
patient's known B cell lymphoproliferative disorder. 
Rearranged Ig or Tcr: n/a. 
Pathology: Cellular aspirate with prominent population 
of 'blast-like' large cells with dispersed chromatin, 
distinct nucleoli and modest amounts of blue, agranular 
cytoplasm. 
Electron microscopy: n/a. 
Precise diagnosis: Acute myelogenous leukemia and 
chronic lymphocytic leukemia. 
Survival 
Date of diagnosis: 01-2002. 
Treatment: Induction: ADE consisting of daunorubicin, 
cytarabine and etoposide plus PSC-833 (he was 
randomized to the treatment arm) on CALGB 19808. 
Consolidation with high-dose cytarabine and etoposide 
with stem cell harvest as per CALGB 19808. Auto stem 
cell transplant: on April 24, 2002. Conditioning 
regimen consisted of busulfan and etoposide as per 
CALGB 19808. 
Complete remission: + on BM on Feb 8, 2002 
Treatment related death: -; 
Relapse: + June 17, 2003; 
Phenotype at relapse: AML M0; 
Status: Dead (06-2003); 
Survival: 21 months. 
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Karyotype 
Sample: Bone Marrow; Culture time: 24 h; Banding: 
GTG. 
Results: 46,XY,t(4;12)(q11-12;p13)[18]/46,XY[2] 
Karyotype at relapse: 46,XY,t(4;12)(q11-q2;p13),+16,-
17[1]/46,XY[19] 
Other molecular studies 
Technics: FISH with LSI (TEL/AML1 ES Dual Color  
Translocation Probe (Vysis, Inc.)) on metaphases. 
Results : ish der(4)(dimTEL+), der(12)(dimTEL+). 
Comments 
The findings are consistent with AML. Although 
histologic features of chronic lymphocytic leukemia  
(CLL) are not seen, flow cytometric analysis shows a 
small subset of monoclonal B cells, consistent with 
persistent involvement by the patient's known CLL. 
 
 
Partial GTG-banding karyotype showing t(4;12)(q11;p13) (a). Partial FISH analysis showing the ETV6 hybridization signals on derivative 
chromosomes 4 and 12, and on the normal chromosome 12 (b). 
 
 
This article should be referenced as such: 
Dal Cin P, DeAngelo DJ, Stone RM. A t(4;12)(q11;p13) in a 
patient with coincident CLL at the same time of AML diagnosis. 
Atlas Genet Cytogenet Oncol Haematol. 2008;12(2):188-189.  
 
 
